Clarendon Lawyers has advised a wholly-owned subsidiary of Eurofins Scientific SE (EPA:ERF) (Eurofins) on its acquisition of Chemical Analysis Pty Ltd (Chemical Analysis), a leading pharmaceutical contract analytical testing laboratory, from iX Biopharma Ltd (SGX:42C).
Eurofins is an international life sciences company which provides a unique range of analytical testing services to clients across multiple industries. Eurofins has an international network of more than 800 laboratories across 47 countries in Europe, North and South America and the Asia-Pacific region. Clarendons have advised Eurofins on several acquisitions in Australia over a number of years.
The Clarendons team was led by Managing Director, Tony Symons and Senior Associate, Brendan Sheehan, who were assisted by Ferguson Ryder. Completion occurred on 15 March 2019.
Mr Symons congratulated Eurofins on the acquisition, noting: “It has been a pleasure to have advised Eurofins on the acquisition of another laboratory business to further expand its footprint in Australia. Eurofins is the world leader in food, environment and pharmaceutical products testing and in agroscience CRO services and we are delighted to have advised them on a number of their recent acquisitions in Australia. Chemical Analysis has earned a reputation for being a premium laboratory in terms of quality, technology, technical expertise and delivery and this acquisition will further enhance Eurofins’ presence in pharmaceutical testing services in Australia.”